According to recent findings in the medical community, prostate cancer is the most common type of cancer among men. As a way to establish more awareness of this condition, the National Football League Alumni Association and Cancer Treatment Centers of America are collaborating to educate a number of men along with providing more access to screenings. Starting in September, men who are age 40 and older will be eligible to sign up to receive a Prostate Specific Antigen screening by the company LabCorp at any location. After the first 2,000 screening slots are filled up, men will be able to schedule a screening at a discount price of only $25 as long as a screening is scheduled within six months of the original sign up date.
Cancer Treatment Centers of America is a large healthcare company based in Boca Raton, Florida. It specializes in treating various forms of cancer to both male and female patients. Over the course of its existence, this healthcare company has established itself as a leader in providing quality assistance to those who are suffering from cancer. With a number of qualified professionals, treatments and procedures, Cancer Treatment Centers of America has proven itself to be a leading medical institution in the United States. As of today, the company has a number of locations throughout the United States. Therefore, people can get the care they need in a variety of regions all over the nation.
This company provides patients with a state of the art facility to receive care. Anyone who comes to any Cancer Treatment Centers of America location will be in position to consult with a professional about their ailments. They will also have professionals available to screen them and provide them with a medical evaluation. There are a number of surgical and radiation treatments that patients can take advantage of when looking to treat cancer at this institution. Cancer Treatment Centers of America has been known to be arguably the best alternative to traditional hospitals and healthcare clinics when suffering from cancer.